<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Rizzo, Toni</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Antman, Elliott</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Balancing Bleeding and Ischemic Risk in the Acute and Long-Term Setting</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2012</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2012-12-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">30-32</style></pages><abstract><style  face="normal" font="default" size="100%">This article discusses issues in balancing the treatment of ischemic risk with bleeding associated with anticoagulant and antiplatelet therapies. The TRITON TIMI-38 study evaluated the time dependence of the association of bleeding with mortality in acute coronary syndrome patients undergoing planned percutaneous coronary intervention [Hochholzer W et al. Circulation 2011].</style></abstract><number><style face="normal" font="default" size="100%">18</style></number><volume><style face="normal" font="default" size="100%">12</style></volume></record></records></xml>